Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin

BACKGROUND: Hepatic encephalopathy (HE), a common neurologic complication in cirrhosis, is associated with substantial disease and economic burden. Rifaximin is a non-systemic antibiotic that reduces the risk of overt HE recurrence and overt HE-related hospitalizations. OBJECTIVE: Our objective was...

Descripción completa

Detalles Bibliográficos
Autores principales: Neff, Guy, III, Woodie Zachry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999147/
https://www.ncbi.nlm.nih.gov/pubmed/29651649
http://dx.doi.org/10.1007/s40273-018-0641-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999147/
https://www.ncbi.nlm.nih.gov/pubmed/29651649
http://dx.doi.org/10.1007/s40273-018-0641-6

Ejemplares similares